• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Metabolic control of diabetes mellitus en relation to the quality of the medical records].[糖尿病的代谢控制与医疗记录质量的关系]
Aten Primaria. 2000 Dec;26(10):670-6. doi: 10.1016/s0212-6567(00)78749-x.
2
Elevated glycohemoglobin HbA1c is associated with low back pain in nonoverweight diabetics.糖化血红蛋白水平升高与非超重糖尿病患者的腰痛有关。
Spine J. 2019 Feb;19(2):225-231. doi: 10.1016/j.spinee.2018.05.035. Epub 2018 May 31.
3
A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.1型糖尿病灵活强化胰岛素治疗期间胰岛素泵治疗与多次注射的群组随机试验、成本效益分析及社会心理评估:REPOSE试验
Health Technol Assess. 2017 Apr;21(20):1-278. doi: 10.3310/hta21200.
4
The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.血糖控制状况:中国江苏省基层、二级和三级医院 2 型糖尿病门诊患者的横断面研究。
Clin Ther. 2010 May;32(5):973-83. doi: 10.1016/j.clinthera.2010.05.002.
5
Quality of glycaemic control in ambulatory diabetics at the out-patient clinic of Kenyatta National Hospital, Nairobi.内罗毕肯雅塔国家医院门诊流动糖尿病患者的血糖控制质量
East Afr Med J. 2003 Aug;80(8):406-10. doi: 10.4314/eamj.v80i8.8731.
6
Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.在意大利真实临床环境中接受利拉鲁肽治疗的大量糖尿病患者中,基线特征与临床结局之间的相关性。
Clin Ther. 2015 Mar 1;37(3):574-84. doi: 10.1016/j.clinthera.2014.11.015. Epub 2015 Jan 24.
7
Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.糖尿病合并慢性肾脏病患者的血糖控制与抗糖尿病治疗——来自德国慢性肾脏病(GCKD)队列的横断面数据
BMC Nephrol. 2016 Jun 11;17(1):59. doi: 10.1186/s12882-016-0273-z.
8
[Cross-sectional epidemiological study of clinical profiles and glycemic control in diabetic patients in primary care in Spain (the EPIDIAP study)].[西班牙初级保健中糖尿病患者临床特征与血糖控制的横断面流行病学研究(EPIDIAP研究)]
Endocrinol Nutr. 2009 May;56(5):233-40. doi: 10.1016/S1575-0922(09)71406-8. Epub 2009 Jul 1.
9
A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in Tshwane primary health care clinics, South Africa.一项整群随机试验,旨在评估南非茨瓦内初级卫生保健诊所的移动筛查及治疗反馈对糖化血红蛋白(HbA1c)和糖尿病相关并发症的影响。
Prim Care Diabetes. 2017 Dec;11(6):546-554. doi: 10.1016/j.pcd.2017.05.010. Epub 2017 Jul 6.
10
Management of type 2 diabetes in Western Australian metropolitan general practice.西澳大利亚州大都市全科医疗中2型糖尿病的管理
Diabetes Res Clin Pract. 1994 Dec 31;26(3):197-208. doi: 10.1016/0168-8227(94)90061-2.

引用本文的文献

1
[Diabetic patient control in Primary Care: Influence of service portfolio and other factors].[初级保健中的糖尿病患者管理:服务组合及其他因素的影响]
Aten Primaria. 2020 Nov;52(9):617-626. doi: 10.1016/j.aprim.2020.02.015. Epub 2020 Jun 21.
2
[Are we taking notice of the glycosilated haemoglobin result when treating our diabetic patients?].在治疗糖尿病患者时,我们是否关注糖化血红蛋白结果?
Aten Primaria. 2002 Jul-Aug;30(3):157-62. doi: 10.1016/s0212-6567(02)78996-8.

本文引用的文献

1
[Evaluation of factors related with glycemia control in type-2 diabetes mellitus].[2型糖尿病血糖控制相关因素的评估]
Aten Primaria. 1999 Jun 15;24(1):39-43.
2
Insulin response in a triethnic population: effects of sex, ethnic origin, and body fat. Miami Community Health Study.三族裔人群的胰岛素反应:性别、族裔出身和体脂的影响。迈阿密社区健康研究。
Diabetes Care. 1997 Nov;20(11):1670-76. doi: 10.2337/diacare.20.11.1670.
3
[The prediction of the degree of metabolic control by minimal technical norms in a diabetes program].[通过糖尿病项目中的最低技术规范预测代谢控制程度]
Aten Primaria. 1997 Apr 15;19(6):313-6.
4
The impact of cardiovascular disease on people with diabetes: the potential for prevention.心血管疾病对糖尿病患者的影响:预防的可能性。
Lancet. 1997 Jul;350 Suppl 1:SI29-32. doi: 10.1016/s0140-6736(97)90026-x.
5
Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.糖尿病周围感觉神经病变的危险因素。西雅图前瞻性糖尿病足研究结果。
Diabetes Care. 1997 Jul;20(7):1162-7. doi: 10.2337/diacare.20.7.1162.
6
Age and sex effects on HbA1c. A study in a healthy Chinese population.年龄和性别对糖化血红蛋白(HbA1c)的影响。一项针对中国健康人群的研究。
Diabetes Care. 1997 Jun;20(6):988-91. doi: 10.2337/diacare.20.6.988.
7
[The validity of basal blood glucose in the control of non-insulin-dependent diabetic patients].[基础血糖在非胰岛素依赖型糖尿病患者控制中的有效性]
Med Clin (Barc). 1997 Mar 8;108(9):325-9.
8
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia.非胰岛素依赖型糖尿病并发症模型。II. 以血糖正常为目标治疗非胰岛素依赖型糖尿病的健康益处和成本效益分析。
Diabetes Care. 1997 May;20(5):735-44. doi: 10.2337/diacare.20.5.735.
9
[Non-insulin dependent diabetes mellitus: care in an area of Barcelona].[非胰岛素依赖型糖尿病:巴塞罗那某地区的护理]
Med Clin (Barc). 1997 Jan 25;108(3):91-7.
10
[Allocation of resources for the health care of diabetics. Panel of Experts, Ministry of Health and Consumption].[卫生与消费部专家小组关于糖尿病患者医疗保健资源分配的报告]
Aten Primaria. 1996 Apr 30;17(7):471-9.

[糖尿病的代谢控制与医疗记录质量的关系]

[Metabolic control of diabetes mellitus en relation to the quality of the medical records].

作者信息

Segovia Pérez C, Maín Pérez A, Corral Cuevas L, González María E, Raquejo Grado M A, Martín Tomero E, de Pablos Heredero A, López Rodríguez A, Hidalgo Santos J C

机构信息

Centros de Salud de Rioza, Nava de la Asunción, Villacastín y Sepúlveda, Segovia.

出版信息

Aten Primaria. 2000 Dec;26(10):670-6. doi: 10.1016/s0212-6567(00)78749-x.

DOI:10.1016/s0212-6567(00)78749-x
PMID:11200510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7681401/
Abstract

OBJECTIVE

To investigate whether there is a relationship between the quality of the clinical history (CH) in primary care and metabolic control of patients with diabetes (DM).

DESIGN

Retrospective and observational.

SETTING

15 health centres in the Segovia Area.

PATIENTS

315 diabetic patients, selected at random from among those with a record of the type of DM, date and outcome of at least one HbA1c and treatment at the time of the most recent HbA1c.

RESULTS

The quality of the clinical histories was measured through the mean of recording of the following items in the 13 months previous to the most recent HbA1c: weight and height, peripheral pulses, sensitivity, foot examination, creatinine, proteinuria, microalbuminuria, glucaemia levels, back of eye, ECG, and diet, tobacco and alcohol counselling. Other variables that could condition the HbA1c, chronic pathologies and those related to DM, were gathered too. Of patients treated with diet or oral diabetic drugs, patients with a clinical history of < or = 49% quality had a mean HbA1c of 7.40%, whereas those with CH of > or = 50% quality had an average of 6.94% (0.46 difference; 95% CI, 0.03-0.90; p = 0.038). This drop was not attributable to age, gender, years of evolution or BMI differences. The risk of having an HbA1c > or = 7.5% is double in patients with a CH of < or = 49% quality than in those with CH of > or = 50% quality (OR = 2.06; 95% CI, 1.14-3.72). In insulin-treated patients, no association between CH quality and HbA1c was found.

CONCLUSIONS

Follow-up of the recommendations for clinical action is associated with better metabolic control in diabetics treated with diet--oral diabetic drugs. This association was not found in insulin-treated patients.

摘要

目的

调查初级保健中临床病史(CH)的质量与糖尿病(DM)患者代谢控制之间是否存在关联。

设计

回顾性观察研究。

地点

塞哥维亚地区的15个健康中心。

患者

315例糖尿病患者,从有DM类型记录、至少一次糖化血红蛋白(HbA1c)日期及结果以及最近一次HbA1c时治疗情况的患者中随机选取。

结果

通过在最近一次HbA1c之前13个月记录以下项目的平均值来衡量临床病史质量:体重和身高、外周脉搏、感觉、足部检查、肌酐、蛋白尿、微量白蛋白尿、血糖水平、眼底、心电图以及饮食、烟草和酒精咨询。还收集了其他可能影响HbA1c的变量、慢性疾病以及与DM相关的变量。在接受饮食或口服降糖药治疗的患者中,临床病史质量≤49%的患者平均HbA1c为7.40%,而临床病史质量≥50%的患者平均为6.94%(差异为0.46;95%可信区间,0.03 - 0.90;p = 0.038)。这种下降并非归因于年龄、性别、病程或体重指数差异。临床病史质量≤49%的患者HbA1c≥7.5%的风险是临床病史质量≥50%患者的两倍(比值比 = 2.06;95%可信区间,1.14 - 3.72)。在接受胰岛素治疗的患者中,未发现临床病史质量与HbA1c之间存在关联。

结论

遵循临床行动建议与接受饮食 - 口服降糖药治疗的糖尿病患者更好的代谢控制相关。在接受胰岛素治疗的患者中未发现这种关联。